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Abstract
Rationale Preoperative biliary drainage (PBD) has been introduced to improve outcome after surgery in patients suffering
from obstructive jaundice due to a potentially resectable proximal or distal bile duct/pancreatic head lesion. In experimental
models, PBD is almost exclusively associated with beneficial results: improved liver function and nutritional status;
reduction of systemic endotoxemia; cytokine release; and, as a result, an improved immune response. Mortality was
significantly reduced in these animal models. Human studies show conflicting results.
Findings For distal obstruction, currently the “best-evidence” available clearly shows that routine PBD does not yield the
appreciated improvement in postoperative morbidity and mortality in patients undergoing resection. Moreover, PBD harbors
its own complications. However, most of the available data are outdated or suffer from methodological deficits.
Conclusion The highest level of evidence for PBD to be performed in proximal obstruction, as well as over the preferred
mode, is lacking but, nevertheless, assimilated in the treatment algorithm for many centers. Logistics and waiting lists,
although sometimes inevitable, could be factors that might influence the decision to opt for PBD, as well as an extended
diagnostic workup with laparoscopy (on indication) or scheduled preoperative chemotherapy.
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Obstructive Jaundice
Malignant disease of the extrahepatic distal (pancreatic head
area) or proximal biliary tract is the most prevalent cause of
obstructive jaundice, clinically evident by jaundiced skin,
nausea, pruritus, dark urine and discoloration of stool, and
the first presenting symptom in up to 90% of the patients.
The hazardous consequence of prolonged and progressive
obstructive jaundice is hepatic dysfunction due to bile stasis
and cholangitis, eventually leading to hepatic failure.
In western countries, pancreatic cancer currently is the
fourth cancer type for death, with an incidence of 10–15 per
100,000, whereas the reported incidence of extrahepatic
cholangiocarcinoma (CCA) is approximately 1 per 100,000.1
Radical resection of the tumor is the only possible treatment
for cure. Pancreatic head tumors and distal CCA are
managed by pancreatoduodenectomy (PD), while for prox-
imal or hilar (Klatskin) extrahepatic CCA affecting the CBD,
hilar resection with partial hepatectomy is indicated. Unfor-
tunately, locoregional irresectability and/or metastatic
disease, which may become apparent during preoperative
work-up, preclude resection in the majority of patients.
Although the postoperative mortality after extensive
hepatopancreatobiliary surgery has decreased from 20% to
less than 5% in experienced centers, the overall morbidity
remains high at approximately 40–60%, depending on
applied definitions.2–6 Frequently encountered surgical
complications are anastomotic leakage, in particular, pan-
creaticojejunostomy leakage, hemorrhage, delayed gastric
emptying, and impaired wound healing. Nowadays, com-
plications are generally managed nonoperatively, mainly
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due to an emerging role of the interventional radiologist.7
Nonsurgical complications consist primarily of sepsis,
pneumonia, and renal disorders.
Already in 1935, this increased risk of surgery in jaundiced
patients was acknowledged by A.O. Whipple, and he was the
first to introduce the concept of preoperative biliary drainage
(PBD) by performing a staged PD: application of a cholecys-
togastrostomy to reduce jaundice was followed by resection at
a later stage, depending on the severity of jaundice.8 In the
mid 1960s, a nonoperative, external drainage procedure was
devised: percutaneous transhepatic cholangiography (PTC)
was performed using the CIBA needle.9 Internal drainage
came up in the seventies when the concept of endoscopic
retrograde cholangiopancreatography (ERCP) was intro-
duced. In one procedure, a diagnostic investigation was
combined with a therapeutic intervention by inserting an
endoprosthesis. Up to now, most patients with distal
obstruction (pancreatic head/distal bile duct) are treated with
ERCP, whereas in patients with proximal biliary obstruction,
PTC is generally the preferred method.
The present article will focus on the role of PBD to
reduce septic complications following surgery for distal and
proximal biliary obstruction by considering the best
evidence available in literature.
Experimental Studies
Obstructive Jaundice
Obstructive jaundice is associated with a proinflammatory
state, resulting from portal and systemic endotoxemia, and
experimental studies have extensively reported on the
processes that are implicated in the underlying pathophys-
iological mechanisms; the most elucidated are discussed
hereafter.10–12
The endotoxin concentration in the portal circulation is
increased, as a result of lack of bile salts in the gut lumen
with, consequently, an unbalanced bacterial intestinal
microflora and increased permeability of the intestinal
mucosal barrier, promoting translocation of bacteria.13,14
Inadequate clearance of endotoxins in obstructive jaundice
has been attributed to an altered reticuloendothelial system
(RES) function of Kuppfer cells in the liver.14,15 Recently,
it has been demonstrated that, in isolated liver Kuppfer cells
from cholestatic mice, increased numbers of viable intra-
cellular bacteria after infection were present, suggesting an
impaired intracellular bacterial killing.16 The exact con-
sequence with respect to development of infectious com-
plications remains to be elucidated.
The exposure to endotoxemia and bacterial translocation
due to obstructive jaundice leads to an uncontrolled
induction of the inflammatory cascade: animal experiments
have shown increased concentrations of proinflammatory
cytokines, such as tumor necrosis factor (TNF), IL-6, GRO/
KC (IL-8), and IL-10.17–22 Increased concentrations of
TNF, mainly produced by liver Kuppfer cells, or rather, the
imbalance with its soluble receptors, as antagonists and
released from the cell membrane by endotoxemia, are
suggested to contribute to development of complica-
tions.18,23 After endotoxin administration to cholestatic
rats, Kennedy et al. demonstrated that blockade of Kuppfer
cells with gadolinium chloride leads to a lower systemic
TNF activity and subsequently resulted in an improved
survival.17 On the other hand, the enhanced IL-6 release, as
found in jaundiced mice exposed to endotoxin, might
actually play an important role in protecting the cholestatic
host against hypersensitivity to endotoxin and was found to
abrogate cholestatic liver injury.22,24 In the perspective of
these results found in animal models of biliary obstruction,
it appears that the generalized inflammatory state in patients
with obstructive jaundice was profoundly different.25
Although obstructive jaundice caused alterations in circu-
lating concentrations of endotoxin-binding proteins, neu-
trophil activation and increased concentrations of IL-8, the
concentrations of many of the investigated mediators in
animals, such as TNF and its receptors, were not as high in
patients.25 Although biliary drainage did reduce IL-8 and
endotoxin binding proteins, it did not change many of the
mediators suggested to correlate with mortality in animal
experiments.
It was demonstrated that cellular immunity, measured by
the lymphocyte response to mitogens (concanavalin-A and
phytohemagglutinin), was significantly lower in bile duct
ligated rats but did not occur in jaundiced germ-free rats.26
This would imply that hyperbilirubinemia itself does not
contribute to immunosuppression, but rather, increased
levels of gut-derived endotoxins due to obstructive jaundice
are responsible because bilirubin levels in both conven-
tional and germ-free bile duct ligated rats were not
different. Obstructive jaundice also leads to deeply sup-
pressed natural killer (NK) activity of nonparenchymal liver
cells in rats, which can be reversed by biliary drainage of an
adequate duration.27,28 Furthermore, the decrease in NK
cell activity resulted in an enhanced growth of liver
metastases, and supposedly, PBD might help to prevent
liver metastases after surgery.27
Next to an increased risk for development of infectious
complications, obstructive jaundice has been associated
with renal dysfunction, with its extent depending on the
intensity of biliary obstruction.10,29,30 In the pathogenesis
of renal failure, extracellular volume depletion may be an
important factor, and while the observed increases in
plasma renin and aldosterone are logical endocrine
responses to a reduced extracellular water compartment,
there also is a paradoxical rise in plasma atrial natriuretic
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peptide (ANP) in response to biliary obstruction.31 The
raised plasma ANP level might be the result of the passage
of bile components to the blood and is reversed to basal
levels after biliary drainage, thereby improving renal
dysfunction.31,32 Furthermore, myocardial dysfunction in
obstructive jaundice has been suggested to be the con-
sequence of hemodynamic disturbances due to altering
ANP concentrations, while after biliary drainage, a corre-
lation was found between decreasing ANP concentrations
and increasing cardiac output.33
Biliary Drainage
Biliary drainage as a therapeutic method to reduce postop-
erative septic complications has been shown in multiple
experimental models to improve liver function, nutritional
status, and cell-mediated immune function; to reduce
systemic endotoxemia and cytokine release; and, subse-
quently, to improve overall immune response.20,26,34–38
Mortality was significantly reduced in these animal models.
With respect to the preferred route of drainage, internal PBD
was found to be superior to external PBD in terms of
reduction in endotoxemia and mortality by some, whereas
others demonstrated external drainage, although in the short-
term, to lead to a better recovery of cellular immunity than
internal drainage.34,39,40 In jaundiced rats undergoing hepa-
tectomy, both external and internal PBD improved serum
liver function tests; however, a better liver regeneration and
function after hepatectomy was observed after internal
drainage.41
A negative side-effect of biliary drainage is the associ-
ated complications of the procedure itself. In dogs, insertion
of biliary endoprostheses resulted in bile contamination and
severe chronic inflammation of the bile duct.42 This
inflammatory process led to considerable thickening of the
wall in both normal and obstructed bile duct, with
transmural, fibrosing inflammation and, occasionally, ul-
ceration. Two months after removal of the endoprosthesis,
bacterobilia persisted and the bile duct remained inflamed
and dilated, albeit less severe. To put an endoprosthesis in
the bile duct before surgery resulted in higher postoperative
infectious complications, an increased risk of anastomotic
dehiscence, more frequent leakage of infected bile, and
increased abscess formation. It is likely that the infected
bile and the condition of the bile duct wall, as a
consequence of the preoperative stenting, were responsible
for these complications.
Concerning the duration of PBD, it has been suggested
that adequate recovery of hepatic function depends on the
duration of biliary decompression and duration of obstruc-
tive jaundice before decompression.43 A minimum of 4–
6 weeks of preoperative drainage was advised, with even
longer periods proposed for patients with a prolonged
biliary obstruction before decompression. A more recent
study showed that preoperative decompression is necessary
for at least 3 weeks before coagulation and hepatic and RES
function start improving.44
PBD for Distal Obstruction
Patients suspected to have a tumor in the pancreatic head
area (pancreas, distal bile duct, papilla of Vater), without
radiological evidence of irresectability, will undergo an
exploration with the intention of resection of the tumor. In
the preoperative course, a majority of these patients suffer
from symptomatic obstructive jaundice.
For many decades, diagnostic strategies comprised the
performance of an ERCP in patients with obstructive jaundice,
accompanied in most cases with stent placement for PBD as a
therapeutic measure for relief of symptoms. Nowadays, state-
of-the-art radiological techniques offer a higher diagnostic
accuracy than ERCP, require a minimum amount of time, are
noninvasive, and have the advantage of assessing local tumor
extension, as well as distant metastases.45–47 Therefore,
ERCP as a diagnostic tool is considered obsolete in many
countries, although geographical differences do exist. Imple-
mentation of a strategy without diagnostic ERCP is not
generally adapted yet in The Netherlands; a survey revealed
that, prior to referral for further assessment and (surgical)
treatment at the tertiary center, almost 40% of patients
already had ERCP performed, primarily as a diagnostic
procedure.48
The therapeutic effect of PBD, either by means of ERCP
or PTC, has been extensively debated throughout the past
few decades. One of the largest prospective randomized
trials performed in the USA by Pitt et al. concluded that
PBD does not reduce operative risk; however, it increases
hospital cost and, therefore, should not be performed
routinely.49 A systematic review from our institution
summarized all retrospective and prospective studies,
published between 1966 and 2001, with the aim to evaluate
the efficacy of drainage in jaundiced patients, compared to
patients that underwent direct surgical treatment.50 Out-
come measures of the meta-analysis were in-hospital death
rate, overall complications resulting from the treatment
modality (PBD- and surgery-related complications), and
hospital stay. Five randomized controlled studies compris-
ing 302 patients (level I evidence) and 18 cohort studies
comprising 2,853 patients (level II evidence) met inclusion
criteria and were analyzed. Meta-analysis for both level I
and level II studies showed no difference in mortality
between patients who had PBD and those who had surgery
without PBD. However, overall complication rate was
significantly adversely affected by PBD compared with
surgery without PBD; for level I, they were 57% and 42%,
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respectively, indicating a relative risk reduction of 15% and
an absolute risk reduction of 27% in case surgery would be
performed without PBD. Analysis of level II studies
showed equal numbers. If PBD had been without compli-
cations, the complication rate would be in favor of PBD
based on level I studies, and without difference based on
level II studies. Further, overall hospital stay was prolonged
after PBD. In all it, was concluded that the potential benefit
of PBD, in terms of postoperative rates of death and
complications, does not outweigh the disadvantage of the
drainage procedure and therefore should not be performed
routinely, unless further improved PBD techniques would
become available.
The inverse relationship between the institutional vol-
ume of major oncological surgery and the resulting
morbidity and mortality rates is well recognized and the
key reason for a plea for centralization of complex surgical
procedures.4,51 Pisters et al. brought this argument up to
justify PBD to create time for referral of patients to high-
volume tertiary surgical centers, their (retrospective) study
did not demonstrate an increase in the risk of major
postoperative complications associated with PBD and stent
placement.52,53 Logistics in terms of (local) referral pat-
terns, waiting lists, extended diagnostic workup with
laparoscopy (on indication), or scheduled preoperative
chemotherapy could be other plausible factors that might
influence the decision to opt for PBD. Possibly, these
factors are region-specific for, at least in the USA, in the
eastern part of the country, early surgery without drainage is
strongly advocated, whereas in the southern part, PBD is
favored.53 However, ideally, such logistic arguments should
never be decisive in treatment consideration. Furthermore,
even in high case-load centers, a hospital volume-outcome
effect for ERCP and stenting exists, which should be taken
into account in the discussion of whether or not to start with
ERCP and drainage before referral.54,55
It should be mentioned that the prospective studies
included in our meta-analysis largely consisted of a
suboptimal design, while they were not carried out
according to the basic principles of clinical trial reporting
(the CONSORT statement).56 Various (outdated) forms of
internal and external drainage procedures for both proximal
and distal obstruction were included, different durations of
drainage were used, and different surgical procedures were
followed. These possible methodological and reporting
deficiencies might hamper drawing conclusions. Further-
more, due to the time span of included studies, outmoded
PBD techniques and materials inevitably add significantly
to the negative outcome of drainage.
Therefore, we have conceived a large randomized
controlled multicenter trial (in patients needing a PD, distal
obstruction) to obtain the highest level of evidence by
comparing a “PBD strategy” (standard strategy) with that of
an “early-surgery” strategy: the drainage vs. operation
(DROP) trial.57 Primary outcome measure is the incidence
of overall severe complications; secondary outcome mea-
sure includes hospital stay, number of invasive diagnostic
tests, costs, and quality of life.
PBD for Proximal Obstruction
Hilar CCA remains one of the most difficult tumors in
terms of staging and radical treatment.58 Furthermore, the
correct mode of preoperative management is still under
debate.59,60 Most patients with hilar CCA show liver
dysfunction caused by obstructive jaundice, which has
proven to be a significant risk factor in major liver
resection.61–63
As mentioned earlier, animal studies concerning PBD
are convincing in terms of complication reduction; clinical
studies report conflicting results.64–67 Two randomized
controlled trials, in which a PBD strategy was compared
to early-surgery strategy in jaundiced patients, including
patients with proximal lesions, did not display a difference
in perioperative mortality; however, they encountered a
high rate of PBD-procedure-related complications.68,69
Cautious interpretation is warranted as these studies used
outdated techniques; included a variety of causes of biliary
obstruction; and, moreover, comprised only a limited
number of patients with proximal CCA. A prospective
cohort study found a significantly higher rate of infectious
complications if PBD was applied, whereas another study
concluded that routine use of PBD was not justified since
mortality was not significantly different and recovery of
hepatic synthetic function was identical to that of non-
jaundiced patients.70,71
In contrast, Japanese literature is unanimous in advising
and emphasizing the benefit of PBD.72–74 The postopera-
tive mortality rates after major liver resections performed
for hilar CCA in Japan are low, currently between 0% and
9%, for which many consider PBD to be an essential
element in preoperative management.73–76 Most centers
agree that, for tumors requiring extensive liver resection,
biliary drainage of at least the future remnant liver is
necessary to prevent hepatic failure.77 With the introduction
of preoperative portal embolization, to induce hypertrophy
of the future remnant liver, the application of wider
resection margins and the development of new endoscopic
techniques are other factors that have led to a favorable
attitude for a preoperative drainage strategy.78
The technique of PBD for proximal obstruction, as well
as which part of the liver should be drained, is an ongoing
controversy. External drainage by PTC is traditionally the
preferred method for relief of obstructive jaundice due to
proximal obstruction. Endoscopic biliary drainage, al-
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though a less invasive technique, carries the increased risk of
developing cholangitis due to bacterial contamination from
the duodenum.78 Moreover, endoscopic biliary drainage
implicates total biliary drainage (TBD) (entire liver), or at
best, hemihepatic drainage by left or right hepatic duct
drainage, whereas drainage via PTC offers the possibility to
perform more selectively segmental drainage. An argument
for selective biliary drainage (SBD) is the subsequent
induction of hypertrophy of the future remnant liver and
atrophy of the future resected part of the liver.79,80 A
retrospective cohort study investigated 42 consecutive
patients who underwent SBD or TBD before hepatectomy.81
SBD was found not to increase the risk for cholangitis,
compared with TBD. In association with portal vein
embolization, SBD was superior to TBD in promoting
hypertrophy of the future remnant liver, whereby extended
hemihepatectomy could be performed more safely. Although
not in the perspective of PBD, the only existing prospective
randomized controlled trial comparing TBD vs. SBD
appointed patients with unresectable hilar bile duct tumors
to undergo either unilateral or bilateral endoscopic hepatic
duct drainage.82 Unilateral drainage resulted in a higher
technical success rate of stent insertion and a significantly
lower incidence of complications, mainly early cholangitis.
In spite of the presumed advantages of PTC drainage
over endoscopic drainage, it should be noted that no clinical
randomized controlled trials exist regarding the most
optimal route of drainage in terms of complication
reduction and patient burden. Currently, the preferred
technique of biliary drainage prior to surgery for a proximal
bile duct tumor depends mainly on local expertise.
Summary and Conclusion
Obstructive jaundice is the most prevalent symptom in
potentially resectable distal and proximal lesions of the
extrahepatic biliary tract/pancreatic head area. The presence
of toxic substances such as bilirubin and bile salts, impaired
liver function, and altered nutritional status due to obstruc-
tive jaundice have been characterized as factors for the
development of complications. Whereas PBD was to yield
beneficial effects in experimental models, conflicting
results have been observed in human studies. For distal
obstruction, currently, the “best evidence” available clearly
shows that PBD should not be performed routinely.
Unfortunately, most of the available data are outdated, and
hopefully, the large prospective randomized controlled
DROP trial will solve the dilemma of whether or not
PBD, as an additional procedure, improves surgical
outcome to such an extent that postponement to resection
of progressive malignant disease is justified.57 The highest
level of evidence for PBD to be performed in proximal
obstruction, as well as over the preferred mode, is lacking
but, nevertheless, assimilated in the preferred treatment
algorithm for many centers. Logistics pose an undesirable,
although sometimes inevitable, argument to perform PBD.
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